About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Cefuroxime sodium (except for intracameral use)
- Procedure number
- PSUSA/00000615/202204
- Regulatory outcome
- Variation
Documents
Cefuroxime sodium (except for intracameral use) : List of nationally authorised medicinal products - PSUSA/00000615/202204
English (EN) (165.69 KB - PDF)
Cefuroxime sodium (except for intracameral use) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00000615/202204
English (EN) (162.58 KB - PDF)
български (BG) (240.76 KB - PDF)
español (ES) (196.5 KB - PDF)
čeština (CS) (226.34 KB - PDF)
dansk (DA) (197.03 KB - PDF)
Deutsch (DE) (178.15 KB - PDF)
eesti keel (ET) (161.31 KB - PDF)
ελληνικά (EL) (208.07 KB - PDF)
français (FR) (194.09 KB - PDF)
hrvatski (HR) (239.55 KB - PDF)
íslenska (IS) (167.39 KB - PDF)
italiano (IT) (217.03 KB - PDF)
latviešu valoda (LV) (255.07 KB - PDF)
lietuvių kalba (LT) (242.13 KB - PDF)
magyar (HU) (246.36 KB - PDF)
Malti (MT) (258.42 KB - PDF)
Nederlands (NL) (173.73 KB - PDF)
norsk (NO) (174.02 KB - PDF)
polski (PL) (262.53 KB - PDF)
português (PT) (187.37 KB - PDF)
română (RO) (236.51 KB - PDF)
slovenčina (SK) (243.55 KB - PDF)
slovenščina (SL) (218.74 KB - PDF)
Suomi (FI) (159.51 KB - PDF)
svenska (SV) (184.59 KB - PDF)